Report Ocean has published a new research study on the global mice model market, according to which, the market is likely to appreciate at an impressive CAGR of 6.40% during the period from 2020 to 2027. The market stood at US$1.3 bn in 2019.
The report is titled “Global Mice Model Market Size study, by Mice Type ( Inbred Mice, Genetically Engineered Mice, Outbred Mice, Hybrid/Congenic Mice, Conditioned/Surgically Modified Mice, Spontaneous Mutant Mice), by Service (Breeding, Cryopreservation, Quarantine, Rederivation, Model-in licensing, Genetic Testing, Other Services), by Application (Immunology and Inflammation Studies, Endocrine Metabolic Studies, Cardiovascular Studies, Central Nervous System (CNS) Studies, Genetic Studies, Infectious Disease Studies Other Disease Studies), by Technology (CRISPR/CAS9, Microinjection, Embryonic Stem cell Injection, Nuclear Transfer, Other Technologies), by Mice Care Product, Cages, Feed Bedding, Other Care Products), by Company Type (Tier 1 Pharmaceutical Companies, Tier 2 Pharmaceutical Companies, Tier 3 Pharmaceutical Companies) and Regional Forecasts 2020-2027.”
The key factors contributing to the growth of the global mice model market are the rising demand for personalized medicines and the continued developments in the mouse models. The increasing investments in R&D, especially in the pharmaceutical and the biopharmaceutical industries, is adding substantially to the market’s proliferation. Apart from these, the augmenting implications of mouse clinical trials (MCTs) for more prognostic outcomes and continuous innovations in mice models are also driving this market. However, the government enforced regulations and laws regarding the ethical use of animals in research are limiting the market’s development to some extent.
Over the next few years, the rising demand for humanized mice models is projected to create ample growth opportunities in the market for participants, since the humanized versions of mice are valued instruments for performing preclinical experiments in a bid to obtain insight into human biology.
Large Number of Market Players to Drive North America
As per the research report, the key regional market for mice model is North America. The presence favorable infrastructure for R&D and a large pool of market players in the US is the main factor behind the growth of this regional market. Over the coming years, the rise in biomedical research in the US and the increasing preclinical activities by pharmaceutical companies and CROs in North America are expected to boost this market substantially.
Other significant region in the global market is Asia Pacific. Factors, such as large population base and the rising patient pool with chronic diseases that requires extensive treatment are creating lucrative growth opportunities for the Asia Pacific mice model market, states the research report.
Impact of Covid 19 on Global Mice Model Market
The global mice model market is one of the few markets, which have gained positively from the Covid 19 pandemic. Companies have begun to invest in research activities on mice models in order to develop a solution to combat Covid 19. For instance, The Jackson Laboratory commenced the production of ACE2 mice to aid the COVID-19 study.
- The presence favorable infrastructure for R&D is boosting North America mice model market.
- Rising patient pool is creating lucrative growth opportunities for the Asia Pacific.
The global mice model market is segmented into:
By Mice Type
- Inbred Mice
- Genetically Engineered Mice
- Outbred Mice
- Hybrid/Congenic Mice
- Conditioned/Surgically Modified Mice
- Spontaneous Mutant Mice
- Model-in licensing
- Genetic Testing
- Other Services
- Immunology and Inflammation Studies
- Endocrine Metabolic Studies
- Cardiovascular Studies
- Central Nervous System (CNS) Studies
- Genetic Studies
- Infectious Disease Studies
- Other Disease Studies
- Embryonic Stem cell Injection
- Nuclear Transfer
- Other Technologies
By Mice Care Product
- Other Care Products
By Company Type
- Tier 1 Pharmaceutical Companies
- Tier 2 Pharmaceutical Companies
- Tier 3 Pharmaceutical Companies
- North America
- Asia Pacific
- Latin America
- Rest of the World
Companies Mentioned in the Report
- Charles River Laboratories
- The Jackson Laboratory
- Taconic Biosciences Inc.
- JANVIER LABS
- Crown Biosciences
- TransCure bioservices
- Ingenious Targeting Laboratory
READ FULLL REPORT @ https://www.reportocean.com/industry-verticals/sample-request?report_id=bw1489
Company Name: Report Ocean
Contact Person: Nishi Sharma
Email: Send Email
Address:Classic Tower, Rajnagar Extension
State: UP, 201017